Journal Of Clinical Oncology (jco) Podcast
A Clear Answer to the Wrong Question
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:11:53
- More information
Informações:
Synopsis
The AVAPERL trial reveals a significant improvement in progression-free survival with the combination of pemetrexed/bevacizumab compared with bevacizumab alone as maintenance therapy for advanced non- small-cell lung cancer, but the clinically relevant endpoint remains overall survival.